Anthem Capital Management logo

Anthem Capital Management

North America, Maryland, United States, Baltimore

Description

Anthem Capital Management is an early-stage venture capital firm based in Baltimore, Maryland, primarily focusing its investment activities on companies within the Mid-Atlantic states. While the firm maintains a relatively low public profile, its stated mission is to support nascent businesses in this specific geographic region, aligning with a strategy to foster local innovation and growth. This regional focus suggests a hands-on approach, potentially leveraging local networks and expertise to aid portfolio companies.

The firm's primary known investment vehicle is Anthem Capital Management Fund I, L.P., which successfully raised $10,000,000, as indicated by SEC filings from 2017. This fund size positions Anthem Capital Management to participate in seed and early-stage funding rounds, typically offering initial investments that can help startups achieve critical milestones. The capital raised reflects a commitment to supporting a select number of promising ventures rather than a broad portfolio.

Publicly available data indicates a very limited number of disclosed investments, with Enveil being the most prominent example. Enveil, a data security company, received seed funding in which Anthem Capital Management participated. The scarcity of publicly announced portfolio companies makes it challenging to definitively ascertain the firm's precise investment patterns or typical check sizes. However, based on the fund's total capital, it is reasonable to infer that initial investments would likely range from a few hundred thousand dollars to approximately one and a half million dollars, allowing for follow-on participation in subsequent rounds.

Investor Profile

Anthem Capital Management has backed more than 22 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Mobile, Biotechnology.
  • Typical check size: $250K – $1.5M.

Stage Focus

  • Series B (36%)
  • Series A (32%)
  • Series Unknown (23%)
  • Series C (5%)
  • Series E (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Mobile
  • Biotechnology
  • Software
  • Wireless
  • Therapeutics
  • Information Technology
  • Web Browsers
  • Enterprise Software
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Anthem Capital Management frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
Maryland Department of Business and Economic Development
North America, Maryland, United States, Baltimore
Co-Investments: 4
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
KH
North America, North Carolina, United States, Charlotte
Co-Investments: 2
Blumberg Capital
North America, California, United States, San Francisco
Co-Investments: 2
ArrowPath Venture Partners
North America, California, United States, Redwood Shores
Co-Investments: 2
Mid-Atlantic Venture Funds
North America, Pennsylvania, United States, Bethlehem
Co-Investments: 2
AT
North America, Florida, United States, Sarasota
Co-Investments: 4

Which angels does Anthem Capital Management often collaborate with?

PO
North America, District of Columbia, United States, Washington
Shared Deals: 1
PC
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by Anthem Capital Management?

Senseonics

Germantown, Maryland, United States

Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.

BiotechnologyHealth CareMedicalMedical DeviceSensorWearables
Series UnknownJun 5, 2014
Amount Raised: $20,000,000
GlycoMimetics

Gaithersburg, Maryland, United States

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

BiotechnologyHealth CareTherapeutics
Series COct 20, 2009
Amount Raised: $38,000,000
Echo360

Dulles, Virginia, United States

Echo360 combines all of the video capabilities into a single, smart solution that is so easy to manage.

EdTechEducationHigher EducationInformation Technology
Series UnknownOct 30, 2008
Amount Raised: $46,500,000
Siperian

Foster City, California, United States

Siperian is an integrated and model-driven software platform providing mobile driven management solutions for businesses.

AnalyticsLife ScienceMobile
Series EJan 22, 2008
Amount Raised: $25,000,000
RedLasso

King Of Prussia, Pennsylvania, United States

Redlasso is a broadcast media website which allows users to search, clip, and share licensed television and radio content.

BroadcastingDigital MediaMusic
Series ANov 1, 2007
Amount Raised: $6,857,054
Defywire

Reston, Virginia, United States

Defywire offers web-based software to develop wireless connections between teachers, administrators, students and parents.

MobileSoftwareWeb BrowsersWireless
Series UnknownMar 27, 2007
Amount Raised: $7,000,000
GlycoMimetics

Gaithersburg, Maryland, United States

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

BiotechnologyHealth CareTherapeutics
Series BJun 23, 2006
Amount Raised: $15,400,000
Triumfant

Rockville, Maryland, United States

Triumfant offers solutions for malware detection, remediation, monitoring and security management of endpoint computers.

Energy EfficiencyEnterprise SoftwareSecuritySoftware
Series BMar 2, 2006
Amount Raised: $6,000,000
Immune Control

Conshohocken, Pennsylvania, United States

Immune Control a Conshohocken, Pa.-based drug company focused on the treatment of multiple myeloma and other immunological diseases.

Health CareHealth DiagnosticsMedical
Series AJul 14, 2005
Amount Raised: $11,300,000
Defywire

Reston, Virginia, United States

Defywire offers web-based software to develop wireless connections between teachers, administrators, students and parents.

MobileSoftwareWeb BrowsersWireless
Series BApr 26, 2005
Amount Raised: $3,600,000